24СʱÈÈÃŰæ¿éÅÅÐаñ    

±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 459  |  »Ø¸´: 0

uouonono

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] EBR 2017 Full

The European Biopharmaceutical Review (EBR), is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the pan European biopharmaceutical market across Europe, North America & the rest of the developed world. The editorial covers in-depth articles, case studies, meeting and report reviews written by specialists with "hands-on" experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with 'regular feature sections on: Biobusiness, Science and Innovation, Biodiscovery, Biodevelopment, Biomanufacturing plus special focuses on geographic or therapeutic territories. Established in 1997, EBR is now well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and more general life science companies, large pharma companies, supplier groups, regulators, investors, analysts and consultants, thus providing a unique forum for general review of the European life science sector on a regular basis.EBR 2017 Full
0998233692.png


EBR 2017 Full-1
1394751756.png
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : EBR_-_January_2017.pdf
  • 2019-03-21 15:55:43, 5.28 M
  • ¸½¼þ 2 : EBR_-_April_2017.pdf
  • 2019-03-21 15:55:49, 6.09 M
  • ¸½¼þ 3 : EBR_-_July_2017.pdf
  • 2019-03-21 15:55:56, 7.84 M
  • ¸½¼þ 4 : EBR_-_October_2017.pdf
  • 2019-03-21 15:56:04, 8.58 M

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ uouonono µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ʳƷ¹¤³Ìר˶һ־ԸÖк£Ñó309Çóµ÷¼Á +3 СÕÅzxyÕÅ 2026-03-26 5/250 2026-03-27 18:42 by СÕÅzxyÕÅ
[¿¼ÑÐ] Çóµ÷¼Á +4 Áã°Ë# 2026-03-27 4/200 2026-03-27 18:07 by yu221
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á +4 RipcordÉϰ¶ 2026-03-27 4/200 2026-03-27 17:00 by zhyzzh
[¿¼ÑÐ] ²ÄÁÏ292µ÷¼Á +12 éÙËÌ˼ÃÀÈË 2026-03-23 12/600 2026-03-27 15:44 by caszguilin
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤°²È«¹¤³Ì300·Ö£¬Çóµ÷¼Á +4 0857Çóµ÷¼Á. 2026-03-24 4/200 2026-03-27 14:03 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó085600£¬310·ÖÇóµ÷¼Á +5 Àîäì¿É 2026-03-26 5/250 2026-03-27 11:14 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏѧ˶£¬Çóµ÷¼Á 6+5 ÌǺù«888ll 2026-03-22 10/500 2026-03-27 08:18 by hypershenger
[¿¼ÑÐ] 342Çóµ÷¼Á +3 ¼ÓÓÍaÀîzs 2026-03-26 3/150 2026-03-27 00:29 by wxiongid
[¿¼ÑÐ] 341Çóµ÷¼Á +7 ÇàÄûÃÊ1 2026-03-26 7/350 2026-03-27 00:19 by wxiongid
[¿¼ÑÐ] 333Çóµ÷¼Á +7 87639 2026-03-21 12/600 2026-03-26 22:08 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 327Çóµ÷¼Á +7 prayer13 2026-03-23 7/350 2026-03-26 20:48 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 324Çóµ÷¼Á +4 wysyjs25 2026-03-21 4/200 2026-03-26 20:38 by fmesaito
[¿¼ÑÐ] Çóµ÷¼Á +8 Auroracx 2026-03-22 8/400 2026-03-26 19:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö) +9 holy J 2026-03-21 9/450 2026-03-26 15:47 by 161765490
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ¹¤´ó 081700 276Çóµ÷¼Á +4 µØÇòÈÆ×ÅÌ«Ñôת 2026-03-23 4/200 2026-03-26 14:27 by zzll406
[¿¼ÑÐ] »·¾³×¨Ë¶324·ÖÇóµ÷¼ÁÍÆ¼ö +5 ÐùСÄþ¡ª¡ª 2026-03-26 5/250 2026-03-26 12:05 by i_cooler
[¿¼ÑÐ] 293Çóµ÷¼Á +7 ¼ÓÒ»Ò»¾Å 2026-03-24 7/350 2026-03-25 12:02 by userper
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢Çóµ÷¼Á 324 +4 Promise-jyl 2026-03-23 4/200 2026-03-25 11:36 by Sugarlight
[¿¼ÑÐ] 293Çóµ÷¼Á +3 ÌÎÌÎWjt 2026-03-22 5/250 2026-03-22 22:21 by jiangpengfei
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û